Upgrade to SI Premium - Free Trial

Roivant Sciences (ROIV)

35.01 -0.09 (0.26%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/17/26)

Latest Headlines

Roivant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026 July 23, 2026 4:05 PM - StreetInsider Immunovant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026 July 23, 2026 4:05 PM - StreetInsider Form 4 Roivant Sciences Ltd. For: Jul 17 Filed by: Epperly Melissa B, July 21, 2026 9:00 PM - SEC Filing Form 4 Roivant Sciences Ltd. For: Jul 17 Filed by: Oren Ilan July 21, 2026 9:00 PM - SEC Filing Form 4 Roivant Sciences Ltd. For: Jul 17 Filed by: MOMTAZEE JAMES C July 21, 2026 9:00 PM - SEC Filing Arbutus sues Pfizer and BioNTech over LNP patents in 3 countries July 16, 2026 7:30 AM - StreetInsider Arbutus Initiates International Patent Infringement Enforcement Actions Against Pfizer and BioNTech, Receives First Payment From Moderna Settlement Agreement and Announces Intent to Return Capital to July 16, 2026 7:30 AM - StreetInsider Form 4 Roivant Sciences Ltd. For: Jun 30 Filed by: Gline Matthew July 2, 2026 7:06 PM - SEC Filing Form 4 Roivant Sciences Ltd. For: Jun 30 Filed by: Fitzgerald Meghan July 2, 2026 7:04 PM - SEC Filing Form 4 Roivant Sciences Ltd. For: Jun 30 Filed by: Torti Frank July 2, 2026 7:01 PM - SEC Filing Form 4 Roivant Sciences Ltd. For: Jun 30 Filed by: Sukhatme Mayukh July 2, 2026 7:00 PM - SEC Filing Form 4 Roivant Sciences Ltd. For: Jun 29 Filed by: Epperly Melissa B, July 1, 2026 6:34 PM - SEC Filing Form 4 Roivant Sciences Ltd. For: Jun 26 Filed by: MANCHESTER KEITH S June 30, 2026 8:38 PM - SEC Filing Form 4 Roivant Sciences Ltd. For: Jun 26 Filed by: Gold Daniel Allen June 30, 2026 8:30 PM - SEC Filing Form 4 Roivant Sciences Ltd. For: Jun 26 Filed by: QVT Financial LP June 30, 2026 7:59 PM - SEC Filing Form 144 Roivant Sciences Ltd. Filed by: Fitzgerald Meghan June 30, 2026 4:36 PM - SEC Filing Form 144 Roivant Sciences Ltd. Filed by: MANCHESTER KEITH S June 30, 2026 4:26 PM - SEC Filing Form 4 Roivant Sciences Ltd. For: Jun 25 Filed by: Sukhatme Mayukh June 29, 2026 6:23 PM - SEC Filing Form 144 Roivant Sciences Ltd. Filed by: Epperly Melissa B, June 29, 2026 4:41 PM - SEC Filing Form 4 Roivant Sciences Ltd. For: Jun 24 Filed by: Venker Eric June 26, 2026 6:14 PM - SEC Filing Form 144 Roivant Sciences Ltd. Filed by: Sukhatme Mayukh June 26, 2026 4:10 PM - SEC Filing Form 144 Roivant Sciences Ltd. Filed by: Sukhatme Mayukh June 25, 2026 4:34 PM - SEC Filing Form 144 Roivant Sciences Ltd. Filed by: Venker Eric June 24, 2026 4:01 PM - SEC Filing Form 4 Roivant Sciences Ltd. For: Jun 20 Filed by: Pulik Richard June 23, 2026 9:18 PM - SEC Filing Form 4 Roivant Sciences Ltd. For: Jun 20 Filed by: Humes Jennifer June 23, 2026 9:16 PM - SEC Filing Roivant Sciences (ROIV) PT Raised to $36 at Guggenheim May 26, 2026 6:38 AM - StreetInsider Form 4 Roivant Sciences Ltd. For: May 20 Filed by: Venker Eric May 22, 2026 6:26 PM - SEC Filing Form 4 Roivant Sciences Ltd. For: May 20 Filed by: Pulik Richard May 22, 2026 6:22 PM - SEC Filing Form 144 Roivant Sciences Ltd. Filed by: Venker Eric May 22, 2026 4:01 PM - SEC Filing Piper Sandler on Roivant Sciences (ROIV): 'Mosliciguat Ph2 PHocus Takes Center Stage & Catalyst-Rich 2026' May 21, 2026 9:00 AM - StreetInsider Roivant Sciences (ROIV) PT Raised to $40 at Bernstein SocGen Group May 21, 2026 8:55 AM - StreetInsider Roivant Sciences (ROIV) PT Raised at TD Cowen as 'IMVT-1402 Shines In D2T RA' May 21, 2026 7:59 AM - StreetInsider H.C. Wainwright Reiterates Buy Rating on Roivant Sciences (ROIV) May 21, 2026 6:37 AM - StreetInsider Roivant Sciences (ROIV) PT Raised to $42 at Leerink May 21, 2026 6:20 AM - StreetInsider Form S-8 Roivant Sciences Ltd. May 20, 2026 4:40 PM - SEC Filing Form 10-K Roivant Sciences Ltd. For: Mar 31 May 20, 2026 7:17 AM - SEC Filing Form 8-K Roivant Sciences Ltd. For: May 20 May 20, 2026 7:14 AM - SEC Filing Roivant Sciences Ltd. (ROIV) Tops Q4 EPS by 57c May 20, 2026 7:08 AM - StreetInsider Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026 and Provides Business Update May 20, 2026 7:00 AM - Globe NewsWire Form SCHEDULE 13G/A Roivant Sciences Ltd. Filed by: MORGAN STANLEY May 12, 2026 1:20 PM - SEC Filing Immunovant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026, and Provide Business Update on Wednesday, May 20, 2026  May 11, 2026 4:05 PM - StreetInsider Roivant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026 and Provide Business Update on Wednesday, May 20, 2026 May 11, 2026 4:05 PM - StreetInsider Form SCHEDULE 13G/A Roivant Sciences Ltd. Filed by: Ramaswamy Vivek May 6, 2026 9:07 PM - SEC Filing Full Article List